{"transactions":[{"id":1086308,"issuer":{"id":8639,"kind":"organization","name":"ZyVersa Therapeutics, Inc."},"owners":[{"id":77458,"kind":"person","name":"Cashmere Karen A.","position":1,"cik":"0001954546","reported_name":"Cashmere Karen A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Options","published_at":"2025-07-16T16:55:04.000Z","date":"2025-07-11","kind":"grant","planned":false,"acquired":true,"shares":48100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This Form 4 is being filed late as the result of an inadvertent administrative oversight."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options were granted on July 11, 2025, and vest and become exercisable in equal annual installments on the first three anniversaries of the grant date, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":48100,"derivative":{"exercise_price":0.59,"expiration_date":"2035-07-11","underlying":"Common Stock","underlying_shares":48100},"source":{"system":"sec-edgar","filing":"0001641172-25-019858","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1859007/000164117225019858/ownership.xml","form_type":"4"}},{"id":1451615,"issuer":{"id":8639,"kind":"organization","name":"ZyVersa Therapeutics, Inc."},"owners":[{"id":77458,"kind":"person","name":"Cashmere Karen A.","position":1,"cik":"0001954546","reported_name":"Cashmere Karen A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2024-07-19T01:35:14.000Z","date":"2023-05-24","kind":"grant","planned":false,"acquired":true,"shares":572,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option disclosed on this Form 4 was not previously reported due to an administrative oversight."},{"field":"shares","element":"transactionShares","label":"F2","text":"Share and dollar amounts give effect to the issuer's 1-for-35 reverse stock split effectuated on December 4, 2023, and 1-for-10 reverse stock split effectuated on April 25, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests annually in three equal installments commencing on May 24, 2024."}],"balance_after":572,"derivative":{"exercise_price":152.46,"expiration_date":"2033-05-24","underlying":"Common Stock","underlying_shares":572},"source":{"system":"sec-edgar","filing":"0001493152-24-028400","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1859007/000149315224028400/ownership.xml","form_type":"4"}},{"id":2086028,"issuer":{"id":8639,"kind":"organization","name":"ZyVersa Therapeutics, Inc."},"owners":[{"id":77458,"kind":"person","name":"Cashmere Karen A.","position":1,"cik":"0001954546","reported_name":"Cashmere Karen A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Options (right to buy)","published_at":"2022-12-15T00:27:56.000Z","date":"2022-12-12","kind":"grant","acquired":true,"shares":21840,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests in 3 equal annual installments commencing on January 28, 2023."}],"balance_after":21840,"derivative":{"exercise_price":16.36,"expiration_date":"2032-01-28","underlying":"Common Stock","underlying_shares":21840},"source":{"system":"sec-edgar","filing":"0001493152-22-035481","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1859007/000149315222035481/ownership.xml","form_type":"4"}},{"id":2086027,"issuer":{"id":8639,"kind":"organization","name":"ZyVersa Therapeutics, Inc."},"owners":[{"id":77458,"kind":"person","name":"Cashmere Karen A.","position":1,"cik":"0001954546","reported_name":"Cashmere Karen A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Options (right to buy)","published_at":"2022-12-15T00:27:56.000Z","date":"2022-12-12","kind":"grant","acquired":true,"shares":21840,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests in 3 equal annual installments commencing on February 8, 2022."}],"balance_after":21840,"derivative":{"exercise_price":16.36,"expiration_date":"2031-02-08","underlying":"Common Stock","underlying_shares":21840},"source":{"system":"sec-edgar","filing":"0001493152-22-035481","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1859007/000149315222035481/ownership.xml","form_type":"4"}},{"id":2086026,"issuer":{"id":8639,"kind":"organization","name":"ZyVersa Therapeutics, Inc."},"owners":[{"id":77458,"kind":"person","name":"Cashmere Karen A.","position":1,"cik":"0001954546","reported_name":"Cashmere Karen A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Options (right to buy)","published_at":"2022-12-15T00:27:56.000Z","date":"2022-12-12","kind":"grant","acquired":true,"shares":29781,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% of the option is immediately exercisable. The option vested in 3 equal annual installments commencing on April 2, 2020."}],"balance_after":29781,"derivative":{"exercise_price":11.58,"expiration_date":"2029-04-02","underlying":"Common Stock","underlying_shares":29781},"source":{"system":"sec-edgar","filing":"0001493152-22-035481","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1859007/000149315222035481/ownership.xml","form_type":"4"}},{"id":2086025,"issuer":{"id":8639,"kind":"organization","name":"ZyVersa Therapeutics, Inc."},"owners":[{"id":77458,"kind":"person","name":"Cashmere Karen A.","position":1,"cik":"0001954546","reported_name":"Cashmere Karen A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Options (right to buy)","published_at":"2022-12-15T00:27:56.000Z","date":"2022-12-12","kind":"grant","acquired":true,"shares":19854,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the option is immediately exercisable. The option vested in 4 equal annual installments commencing on October 30, 2017."}],"balance_after":19854,"derivative":{"exercise_price":5.03,"expiration_date":"2027-10-30","underlying":"Common Stock","underlying_shares":19854},"source":{"system":"sec-edgar","filing":"0001493152-22-035481","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1859007/000149315222035481/ownership.xml","form_type":"4"}},{"id":2086024,"issuer":{"id":8639,"kind":"organization","name":"ZyVersa Therapeutics, Inc."},"owners":[{"id":77458,"kind":"person","name":"Cashmere Karen A.","position":1,"cik":"0001954546","reported_name":"Cashmere Karen A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Options (right to buy)","published_at":"2022-12-15T00:27:56.000Z","date":"2022-12-12","kind":"grant","acquired":true,"shares":9927,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the option is immediately exercisable. The option vested in 3 equal annual installments commencing on September 10, 2014."}],"balance_after":9927,"derivative":{"exercise_price":5.03,"expiration_date":"2024-09-10","underlying":"Common Stock","underlying_shares":9927},"source":{"system":"sec-edgar","filing":"0001493152-22-035481","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1859007/000149315222035481/ownership.xml","form_type":"4"}}]}